JPMorgan Resumes Nektar Therapeutics (NKTR) at Neutral

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/20/2026

1. TGT
2. EL
3. MRK
4. BILL
5. MRNA
6. COTY
7. RARE
8. LOW
9. DE
10. JKHY

September 14, 2020 5:13 AM EDT
Get Alerts NKTR Hot Sheet
Price: $76.08 --0%

Rating Summary:
    20 Buy, 7 Hold, 5 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 9 | Down: 12 | New: 19
Join SI Premium – FREE

JPMorgan analyst Jessica Fye resumes coverage on Nektar Therapeutics (NASDAQ: NKTR) with a Neutral rating and a price target of $26.00.


For an analyst ratings summary and ratings history on Nektar Therapeutics click here. For more ratings news on Nektar Therapeutics click here.


Shares of Nektar Therapeutics closed at $18.82 yesterday.


You May Also Be Interested In





Related Categories

New Coverage